Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
Holders of 5% or more of NRIX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nurix Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 13.40%10.2M shares | −1.10 ppfrom 14.50% | Dec 6, 20242 filings | May 12, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 8.20%6.28M shares | – | Apr 23, 20251 filing | Apr 23, 2025 | SEC |
| Deep Track Capital, LP | 13G/A | 7.21%5.50M shares | +1.77 ppfrom 5.44% | Feb 14, 20253 filings | May 15, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Nurix Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20255:02 PM ET | Commodore Capital LPand 1 other | 13G/A | 4.90%3.78M shares | −0.20 ppfrom 5.10%Below 5% | Sep 30, 2025 | SEC |
| May 15, 20258:44 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 7.21%5.50M shares | +1.77 ppfrom 5.44% | Mar 31, 2025 | SEC |
| May 12, 202510:44 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 4.20%3.19M shares | –Below 5% | Mar 31, 2025 | SEC |
| May 12, 202510:36 AM ET | FMR LLCand 1 other | 13G/A | 13.40%10.2M shares | −1.10 ppfrom 14.50% | Mar 31, 2025 | SEC |
| Apr 23, 20258:57 PM ET | BlackRock, Inc. | 13G/A | 8.20%6.28M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20254:31 PM ET | Deep Track Capital, LPand 2 others | 13G | 5.44%4.13M shares | +1.20 ppfrom 4.24% | Feb 7, 2025 | SEC |
| Feb 14, 20254:05 PM ET | Commodore Capital LPand 1 other | 13G | 5.10%3.85M shares | New | Feb 7, 2025 | SEC |
| Feb 14, 20258:42 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 4.24%3.00M shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 10, 20259:33 PM ET | ARK Investment Management LLCSuperinvestorARK Invest | 13G/A | 0.00%0 shares | –Below 5% | Sep 30, 2024 | SEC |
| Dec 6, 202411:34 AM ET | FMR LLCand 1 other | 13G | 14.50%10.3M shares | New | Nov 29, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Nurix Therapeutics, Inc. shares.
No Form 144 notices for Nurix Therapeutics, Inc. are on file.